Objective To refine the previously developed scleroderma (systemic sclerosis [SSc]) gastrointestinal tract (GIT) instrument (SSC-GIT 1.0). Methods We administered the SSC-GIT 1.0 and the Short Form 36 to 152 patients with SSc; 1 item was added to the SSC-GIT 1.0 to assess rectal incontinence. In addition, subjects completed a rating of the severity of their GIT involvement (from very mild to very severe). Evaluation of psychometric properties included internal consistency reliability, test–retest reliability (mean time interval 1.1 weeks), and multitrait scaling analysis. Results Study participants were mostly women (84%) and white (81%); 55% had diffuse SSc. Self-rated severity of GIT involvement ranged from no symptoms to very mild (...
Systemic sclerosis (SSc) is a rare systemic, autoimmune disease characterized by vascular changes an...
Objective. To refine the previously developed scleroderma (systemic sclerosis [SSc]) gastrointestina...
Systemic sclerosis (SSc) affects the upper gastrointestinal (GI) system in 90% of patients. High-res...
Objective. To test the acceptability, feasibility, reliability and validity of the Italian translate...
Background/Aims Systemic sclerosis (SSc) is associated with a wide range of gastrointestinal (GI) ch...
ObjectiveGastrointestinal (GI) involvement is common in patients with systemic sclerosis (SSc; scler...
BACKGROUND AND OBJECTIVES The University of California Los Angeles Scleroderma Clinical Trial Con...
Objective: To assess whether patient and physician global assessment of gastrointestinal tract (GIT)...
Objective: Validated gastrointestinal (GI) symptoms scales are used in clinical practice to assess p...
Objectives To evaluate the severity and evolution of patient-reported gastrointestinal tract (GIT) s...
BACKGROUND AND OBJECTIVES: The University of California Los Angeles Scleroderma Clinical Trial Conso...
Objectives: To assess the prevalence and burden of SSc-related gastrointestinal dysfunction (SSc-GI)...
ObjectivesTo evaluate changes in microbial composition and the evolution of gastrointestinal tract (...
Contains fulltext : 175251.pdf (publisher's version ) (Closed access)Objective. Th...
Abstract Objectives: SSc is a clinically heterogeneous and generalized disease, characterized by th...
Systemic sclerosis (SSc) is a rare systemic, autoimmune disease characterized by vascular changes an...
Objective. To refine the previously developed scleroderma (systemic sclerosis [SSc]) gastrointestina...
Systemic sclerosis (SSc) affects the upper gastrointestinal (GI) system in 90% of patients. High-res...
Objective. To test the acceptability, feasibility, reliability and validity of the Italian translate...
Background/Aims Systemic sclerosis (SSc) is associated with a wide range of gastrointestinal (GI) ch...
ObjectiveGastrointestinal (GI) involvement is common in patients with systemic sclerosis (SSc; scler...
BACKGROUND AND OBJECTIVES The University of California Los Angeles Scleroderma Clinical Trial Con...
Objective: To assess whether patient and physician global assessment of gastrointestinal tract (GIT)...
Objective: Validated gastrointestinal (GI) symptoms scales are used in clinical practice to assess p...
Objectives To evaluate the severity and evolution of patient-reported gastrointestinal tract (GIT) s...
BACKGROUND AND OBJECTIVES: The University of California Los Angeles Scleroderma Clinical Trial Conso...
Objectives: To assess the prevalence and burden of SSc-related gastrointestinal dysfunction (SSc-GI)...
ObjectivesTo evaluate changes in microbial composition and the evolution of gastrointestinal tract (...
Contains fulltext : 175251.pdf (publisher's version ) (Closed access)Objective. Th...
Abstract Objectives: SSc is a clinically heterogeneous and generalized disease, characterized by th...
Systemic sclerosis (SSc) is a rare systemic, autoimmune disease characterized by vascular changes an...
Objective. To refine the previously developed scleroderma (systemic sclerosis [SSc]) gastrointestina...
Systemic sclerosis (SSc) affects the upper gastrointestinal (GI) system in 90% of patients. High-res...